Screening and confirmation methods for GHB determination in biological fluids
- 6 February 2014
- journal article
- review article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 406 (15) , 3553-3577
Abstract
The purpose of this review is to provide a comprehensive overview of reported methods for screening and confirmation of the low-molecular-weight compound and drug of abuse gamma-hydroxybutyric acid (GHB) in biological fluids. The polarity of the compound, its endogenous presence, its rapid metabolism after ingestion, and its instability during storage (de novo formation and interconversion between GHB and its lactone form gamma-butyrolactone) are challenges for the analyst and for interpretation of a positive result. First, possible screening procedures for GHB are discussed, including colorimetric, enzymatic, and chromatography-based procedures. Confirmation methods for clinical and forensic cases mostly involve gas chromatography (coupled to mass spectrometry), although liquid chromatography and capillary zone electrophoresis have also been used. Before injection, sample-preparation techniques include (a combination of) liquid–liquid, solid-phase, or headspace extraction, and chemical modification of the polar compound. Also simple “dilute-and-shoot” may be sufficient for urine or serum. Advantages, limitations, and trends are discussed.Keywords
This publication has 121 references indexed in Scilit:
- Response to Stove and colleagues concerning newborn screening of succinic semialdehyde dehydrogenase (SSADH) deficiency in dried blood spotsMolecular Genetics and Metabolism, 2013
- Letter to the EditorMolecular Genetics and Metabolism, 2013
- Determination of gamma-hydroxybutyric acid in biofluids using a one-step procedure with “in-vial” derivatization and headspace-trap gas chromatography–mass spectrometryJournal of Chromatography A, 2013
- Anion exchange SPE and liquid chromatography–tandem mass spectrometry in GHB analysisJournal of Chromatography B, 2011
- Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuseDrug and Alcohol Dependence, 2009
- Trends in γ-Hydroxybutyrate (GHB) and Related Drug Intoxication: 1999 to 2003Annals of Emergency Medicine, 2006
- Laboratory Diagnosis of 1,4-BD and GHB Overdose by Routine Urine Organic Acid AnalysisClinical Toxicology, 2005
- Production of γ-hydroxybutyric acid in postmortem liver increases with time after deathToxicology Letters, 2002
- A Tale of Novel Intoxication: Seven Cases of γ-Hydroxybutyric Acid OverdoseAnnals of Emergency Medicine, 1998
- Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography—mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 1993